Form 4: Colgate-Palmolive Director Defers Compensation into Stock

Colgate-Palmolive Co. Director John P. Bilbrey acquired 289 shares of common stock through a deferred compensation plan.

Summary

• John P. Bilbrey, a Director of Colgate-Palmolive Co. (CL), acquired 289 shares of common stock.
• The transaction occurred on October 1, 2025, at a price of $82.13 per share.
• This acquisition resulted from the deferral of a portion of Mr. Bilbrey's annual cash retainer into a stock unit account, pursuant to the Deferred Compensation Plan for Non-Employee Directors.
• Following this transaction, Mr. Bilbrey directly beneficially owns 36,658 shares of common stock.
• Additionally, Mr. Bilbrey indirectly beneficially owns 4,719 shares of common stock through a trust.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even through a deferred compensation plan, is generally a positive signal as it increases insider ownership and aligns interests with shareholders. However, it is a routine transaction and not a discretionary open-market purchase.

Positives

• Director John P. Bilbrey increased his beneficial ownership in Colgate-Palmolive Co., aligning his interests further with shareholders.
• The acquisition through a deferred compensation plan demonstrates continued commitment to the company by a key board member.

Future Outlook

NA

Industry Context

This filing is specific to an individual director's compensation and equity ownership and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to higher equity ownership.

Key Dates

Recommendation

The Form 4 filing indicates a routine acquisition of shares by a director through a deferred compensation plan. While it shows continued alignment of management interests with shareholders, it does not present new material information that would significantly alter the investment thesis for Colgate-Palmolive Co. The transaction is part of a pre-existing compensation structure and does not reflect a discretionary open-market purchase that might signal a strong belief in immediate stock appreciation or depreciation. Therefore, a 'hold' recommendation is appropriate as the filing does not provide a basis for a change in investment strategy.

Keywords

Colgate-Palmolive, CL, Form 4, Insider Transaction, Director Stock Acquisition, Deferred Compensation, Equity Ownership